Plumbagin Suppresses α-MSH-Induced Melanogenesis in B16F10 Mouse Melanoma Cells By Inhibiting Tyrosinase Activity
Apr 25, 2023
Abstract:
Recent studies have shown that plumbagin has anti-inflammatory, anti-allergic, antibacterial, and anti-cancer activities; however, it has not yet been shown whether plumbagin suppresses alpha-melanocyte stimulating hormone (α-MSH)-induced melanin synthesis to prevent hyperpigmentation. In this study, we demonstrated that plumbagin significantly suppresses α-MSH-stimulated melanin synthesis in B16F10 mouse melanoma cells. To understand the inhibitory mechanism of plumbagin on melanin synthesis, we performed cellular or cell-free tyrosinase activity assays and analyzed melanogenesis-related gene expression. We demonstrated that plumbagin directly suppresses tyrosinase activity independent of the transcriptional machinery associated with melanogenesis, which includes microphthalmia-associated transcription factor (MITF), tyrosinase (TYR), and tyrosinase-related protein 1 (TYRP1). We also investigated whether plumbagin was toxic to normal human keratinocytes (HaCaT) and lens epithelial cells (B3) that may be injured by using skin-care cosmetics. Surprisingly, lower plumbagin concentrations (0.5–1 µM) effectively inhibited melanin synthesis and tyrosinase activity but do not cause toxicity in keratinocytes, lens epithelial cells, and B16F10 mouse melanoma cells, suggesting that plumbagin is safe for dermal application. Taken together, these results suggest that the inhibitory effect of plumbagin on pigmentation may make it an acceptable and safe component for use in skin-care cosmetic formulations used for skin whitening.
According to relevant studies,cistanche is a common herb that is known as "the miracle herb that prolongs life". Its main component is cistanoside, which has various effects such as antioxidant, anti-inflammatory, and immune function promotion. The mechanism between cistanche and skin whitening lies in the antioxidant effect of cistanche glycosides. Melanin in human skin is produced by the oxidation of tyrosine catalyzed by tyrosinase, and the oxidation reaction requires the participation of oxygen, so the oxygen-free radicals in the body become an important factor affecting melanin production. Cistanche contains cistanoside, which is an antioxidant and can reduce the generation of free radicals in the body, thus inhibiting melanin production.

Click on Cistanche Tubulosa Supplement
For more info:
david.deng@wecistanche.com WhatApp:86 13632399501
Keywords: plumbagin; melanogenesis; pigmentation; tyrosinase
1. Introduction
Melanin consists of a group of pigments synthesized in epidermal melanocytes that plays an important role in defending skin against ultraviolet (UV) radiation damage [1]. Abnormal melanogenesis, either increased or decreased production of melanin, is closely associated with several skin diseases including melanoma and the pigmentation disorders, such as chloasma and freckles [2,3]. The biosynthesis of melanin is initiated by multiple stimuli including UV irradiation, inflammatory cytokines, and hormonal signaling. Specifically, α-melanocyte stimulating hormone (α-MSH) released from UV-exposed keratinocytes can stimulate melanin biosynthesis in epidermal melanocytes by activating the cAMP-PKA-CREB (cyclic adenosine monophosphate-protein kinase A-cAMP response element binding protein) axis [3]. The activated cAMP-PKA-CREB axis leads to an increase in mRNA encoding microphthalmia-associated transcription factor (MITF). MITF increases the gene expression of tyrosinase (TYR), tyrosinase-related protein 2 (TYRP1), and tyrosinase-related protein 2 (TYRP2) upon α-MSH stimulation in melanocytes [3,4]. In addition, many signaling pathways that control cell growth, including mitogen-activated protein kinases (MAPKs), extracellular response kinase (ERK), and AKT, are essential to melanogenesis by regulating MITF stability and activity [5].
The enzyme tyrosinase, a multifunctional copper-containing oxidase, plays an essential role in melanin biosynthesis by catalyzing the reactions in which L-tyrosine is hydroxylated to L-dihydroxyphenylalanine (L-DOPA) and L-DOPA is oxidized into o-quinone (dopaquinone) [5,6]. Therefore, some tyrosinase inhibitors also inhibit melanin biosynthesis, and these include resveratrol, arbutin, and honokiol, which have all been used in skin-whitening cosmetic applications [7].

Plumbagin is a simple hydroxyl-naphthoquinone, that was first extracted from the roots of the Plumbago genus of plants and has been shown to have remarkable medicinal properties [8]. Anti-inflammatory, anti-cancer, anti-allergic, and antibacterial activities of plumbagin have been reported [8,9]. Indeed, it has been reported that plumbagin inhibits neutrophil activation, angiogenesis, and collagenase expression by suppressing topoisomerase-II, suggesting the use of plumbagin as a potential drug in the treatment of rheumatoid arthritis [10]. In addition, several reports have shown that plumbagin exhibits anti-cancer activity in multiple types of cancer, including breast [11], prostate [12], ovarian [13], lung [14], skin carcinoma [15], and liver cancer [16]. Although it is becoming clear that plumbagin may be useful as a therapeutic intervention in the treatment of various human diseases, the inhibitory effect of plumbagin on melanogenesis linked to hyperpigmentation has never been reported.
In the present study, we evaluated the inhibitory effects of plumbagin on melanogenesis stimulated by α-MSH. Here we show that plumbagin significantly suppresses α-MSH-induced melanin biosynthesis in B16F10 mouse melanoma cells by inhibiting tyrosinase activity but that it does not inhibit MITF-mediated gene expression associated with melanogenesis.
2. Results
2.1. Chemical Structure and Cytotoxic Effects of Plumbagin in B16F10 Mouse Melanoma Cells
Before studying the anti-melanogenic effects of plumbagin, we first assessed its toxicity in melanin-producing B16F10 mouse melanoma cells. The chemical structure of plumbagin is shown in Figure 1A. The results of our cytotoxicity assay wherein plumbagin concentrations less than 5 µM did not affect cell viability in B16F10 cells are shown in Figure 1B.

2.2. Plumbagin Suppresses α-MSH-Induced Melanin Synthesis in B16F10 Mouse Melanoma Cells
We next investigated the inhibitory effects of plumbagin on α-melanocyte stimulating hormone (α-MSH)-induced melanin synthesis in B16F10 cells. We demonstrated that plumbagin strongly suppresses α-MSH-induced melanin accumulation in a cultured medium of B16F10 cells (Figure 2A). To confirm the inhibitory effect of plumbagin on α-MSH-induced melanin synthesis, we determined the extracellular or intracellular melanin content in the absence or presence of plumbagin in α-MSH-stimulated B16F10 cells. Figures 2B and C show that plumbagin significantly decreases extracellular and intracellular melanin content.

2.3. Plumbagin Does Not Regulate α-MSH-Induced Melanogenesis Gene Expression and Signal Transduction Cascades
Because microphthalmia-associated transcription factor (MITF) is an essential transcription factor that regulates melanogenesis-associated gene expression through the α-MSH-PKA-CREB axis, we investigated whether plumbagin could regulate MITF-mediated gene expression associated with melanogenesis. First, we determined a time point of maximal melanogenesis gene expression for MITF, tyrosinase (TYR), and tyrosinase-related protein 1 (TYRP1) under α-MSH stimulation. MITF is strongly upregulated after α-MSH treatment for 2 h (Figure 3A). TYR and TYRP1 were dramatically upregulated after 48 h of α-MSH treatment (Figure 3A). MITF and tyrosinase protein levels increased in response to α-MSH treatment and were not suppressed by the plumbagin treatment (Figure 3B). Consistently, plumbagin did not inhibit MITF, TYR, and TYRP1 mRNA levels after α-MSH stimulation, suggesting that plumbagin does not regulate the transcriptional machinery related to melanogenesis gene expression in B16F10 cells (Figure 3C). Because phosphorylation and activation of AKT, ERK1/2, and CREB (major signal transduction cascades that regulate melanogenesis) are required for melanogenesis [3], we further investigated whether plumbagin regulates these melanogenesis-associated signal transduction pathways. Our results, described in Figure 3D, show that plumbagin does not alter AKT, ERK1/2, or CREB signaling after α-MSH treatment.

2.4. Plumbagin Inhibits Tyrosinase Activity
Because direct or indirect tyrosinase-inhibiting natural products could be useful for the development of skin-whitening cosmetics, we next investigated the inhibitory effect of plumbagin on tyrosinase enzyme activity. In this study, we demonstrated that plumbagin significantly suppresses α-MSH-induced cellular tyrosinase enzymatic activity in B16F10 cells (Figure 4A). To understand whether plumbagin inhibits tyrosinase activity directly or indirectly, cell-free tyrosinase activity was measured. Plumbagin strongly inhibits the L-DOPA oxidation activity of mushroom-derived tyrosinase as well, suggesting that plumbagin suppresses melanogenesis by directly inhibiting tyrosinase activity (Figure 4B). In addition, signifificant elevation in radical scavenging activities using a 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay was observed in samples treated with vitamin C and plumbagin at concentrations ranging from 0.1 to 5 mg/mL. Consequently, 5 mg/mL of plumbagin exhibited a similar effect on radical scavenging activity to those of 0.1 mg/mL of vitamin C (Figure 4C).

2.5. Plumbagin Is Not Toxic in Normal Keratinocytes and Lens Epithelial Cells
Because cosmetics such as skin cream are for external use and cytotoxicity could cause skin problems, we further investigated whether plumbagin is toxic to normal keratinocytes (HaCaT) and lens epithelial cells (B3) and whether it may be useful for the development of skin-whitening cosmetics. Consequently, we found that lower plumbagin concentrations (1–5 µM) do not cause toxicity in HaCaT and B3 cells, but are effective in the inhibition of melanin synthesis (Figure 5A). In addition, plumbagin did not induce DNA damage-related γH2AX and reduce cellular apoptosis-related poly (ADP-ribose) polymerase (PARP) and caspase-3 proteins in HaCaT and B3 cells (Figure 5B), suggesting that plumbagin may be acceptable for use in skin-whitening products without exhibiting any dermal toxicity.

3. Discussion
Plumbagin is a plant-derived secondary metabolite and shows several biological functions, including anti-inflammatory, anti-cancer, anti-allergic, and antibacterial activities [8,9]. However, it was not known whether plumbagin had an inhibitory effect on melanogenesis linked to hyperpigmentation and melanoma. In this study, we demonstrated that plumbagin strongly suppresses melanogenesis in B16F10 melanoma cells, and this work could provide an opportunity for developing skin-care cosmetics based on the anti-inflammatory, anti-allergic, antibacterial, and anti-melanogenesis activities of plumbagin.
Because upregulation of melanogenesis is often observed in malignant melanoma with overexpressed tyrosinase levels in the blood as well as tumor tissues, it is apparent that melanogenesis is a potential target for chemotherapy of malignant melanomas [1]. In the present study, we found that plumbagin directly suppresses tyrosinase activity independent of the transcriptional machinery associated with melanogenesis (Figure 6). Therefore, our results suggest that plumbagin may be a potential component of a preventive and therapeutic strategy for the management of malignant melanoma. Indeed, the anti-melanoma, chemosensitizing, and radiosensitizing effects of plumbagin on melanoma therapy have been reported [17–21].

In previous studies dealing with the anti-cancer and anti-inflammatory effects of plumbagin, approximately 5–10 µM of plumbagin (higher than the concentration used in this study) has been used in in vitro models [17,22,23]. Therefore, we investigated the toxic effect of plumbagin in proliferative cells, including normal keratinocytes (HaCaT) and lens epithelial cells (B3), that can be damaged by skin-care cosmetics. Our results demonstrated that lower concentrations, approximately 0.5–1 µM of plumbagin, are not toxic to normal keratinocytes and lens epithelial cells, but are effective enough to reduce tyrosinase activity and melanin synthesis. In addition, we also found that plumbagin more effectively suppresses melanogenesis than 1 mM arbutin or 0.2 mM kojic acid, which is well-known skin-whitening agents. These results suggest that plumbagin is safe for use as a component for developing skin-whitening cosmetics.
4. Materials and Methods
4.1. Reagents and Antibodies
4.2. Cell Culture and Cell Viability Assay
4.3. Immunoblotting
Cultured cells were lysed using 1% IGEPAL (octylphenoxypolyethoxyethanol), 150 mM NaCl, 50 mM Tris-HCl (pH 7.9), 10 mM NaF, and a protease inhibitor cocktail in lysis buffer. Protein samples were separated via sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and the separated proteins were then transferred to a polyvinylidene difluoride (PVDF) membrane (Millipore, Billerica, MA, USA). Membranes were incubated overnight with primary antibodies (1:1000) at 4 ◦C, and then incubated with HRP-conjugated secondary antibodies (1:10,000) for 1 h at room temperature. Proteins were visualized using an ECL Prime kit (GE Healthcare, Pittsburgh, PA, USA).

4.4. Measurement of Intracellular and Extracellular Melanin Content
Melanin content was determined and quantified using a previously described method with slight modification [2,24]. For melanin content analysis, B16F10 cells were cultured in phenol red-free DMEM containing 10% fetal bovine serum. B16F10 cells were cultured with α-MSH treatment in the absence or presence of plumbagin for 3 or 4 days. The cultured cells or media were harvested and pellets were dissolved in 1N NaOH containing 10% DMSO at 80 ◦C for 1 h. The melanin content was measured using an absorbance reader at 475 nm (OD475), and melanin content was then normalized to the cellular protein concentration.
4.5. RNA Isolation and Quantitative RT-PCR
4.6. Cellular Tyrosinase Activity Assay
Cellular tyrosinase activity was determined using a previously described method with modification [25,26]. Cultured B16F10 cells were incubated with α-MSH in the absence or presence of plumbagin, and cells were then washed and lysed with PBS containing 1% sodium deoxycholate and 0.5% Triton X-100. After the protein concentration was determined, 50 µg of protein was incubated with 2.0 mM L-DOPA and 0.1 M PBS (pH 6.8) for 1 h at 37 ◦C. The oxidation of L-DOPA was measured at 475 nm (OD475) using an absorbance reader. The activity was measured using the following formula: tyrosinase activity (%) = (OD475 of sample/OD475 of control) × 100.
4.7. Cell-Free Tyrosinase Activity Assay
4.8. DPPH Radical Scavenging Activity Assay
4.9. Statistical Analysis
5. Conclusions

References
1. Riley, P.A. Melanogenesis and melanoma. Pigment Cell Res. 2003, 16, 548–552. [CrossRef] [PubMed]
2. Bae, J.S.; Han, M.; Yao, C.; Chung, J.H. Chaetocin inhibits IBMX-induced melanogenesis in B16F10 mouse melanoma cells through activation of ERK. Chem. Biol. Interact. 2016, 245, 66–71. [CrossRef] [PubMed]
3. D’Mello, S.A.; Finlay, G.J.; Baguley, B.C.; Askarian-Amiri, M.E. Signaling pathways in melanogenesis. Int. J. Mol. Sci. 2016. [CrossRef] [PubMed]
4. Kim, H.J.; Yonezawa, T.; Teruya, T.; Woo, J.T.; Cha, B.Y. Nobiletin, a poly ethoxy flflavonoid, reduced endothelin-1 plus SCF-induced pigmentation in human melanocytes. Photochem. Photobiol. 2015, 91, 379–386. [CrossRef] [PubMed]
5. Kang, S.J.; Choi, B.R.; Lee, E.K.; Kim, S.H.; Yi, H.Y.; Park, H.R.; Song, C.H.; Lee, Y.J.; Ku, S.K. Inhibitory effect of dried pomegranate concentration powder on melanogenesis in B16F10 melanoma cells; involvement of p38 and PKA signaling pathways. Int. J. Mol. Sci. 2015, 16, 24219–24242. [CrossRef] [PubMed]
6. Kim, J.W.; Kim, H.I.; Kim, J.H.; Kwon, O.C.; Son, E.S.; Lee, C.S.; Park, Y.J. Effects of ganodermanondiol, a new melanogenesis inhibitor from the medicinal mushroom Ganoderma lucidum. Int. J. Mol. Sci. 2016, 17, 1798. [CrossRef] [PubMed]
7. Tsao, Y.T.; Huang, Y.F.; Kuo, C.Y.; Lin, Y.C.; Chiang, W.C.; Wang, W.K.; Hsu, C.W.; Lee, C.H. Hinokitiol inhibits melanogenesis via AKT/mTOR signaling in B16F10 mouse melanoma cells. Int. J. Mol. Sci. 2016, 17, 248. [CrossRef] [PubMed]
8. Padhye, S.; Dandawate, P.; Yusufifi, M.; Ahmad, A.; Sarkar, F.H. Perspectives on medicinal properties of plumbagin and its analogs. Med. Res. Rev. 2012, 32, 1131–1158. [CrossRef] [PubMed]
9. Gupta, S.C.; Kim, J.H.; Prasad, S.; Aggarwal, B.B. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev. 2010, 29, 405–434. [CrossRef] [PubMed]
10. Jackson, J.K.; Higo, T.; Hunter, W.L.; Burt, H.M. Topoisomerase inhibitors as anti-arthritic agents. Inflflamm. Res. 2008, 57, 126–134. [CrossRef] [PubMed]
11. Ahmad, A.; Banerjee, S.; Wang, Z.; Kong, D.; Sarkar, F.H. Plumbagin-induced apoptosis of human breast cancer cells is mediated by inactivation of NF-κB and Bcl-2. J. Cell. Biochem. 2008, 105, 1461–1471. [CrossRef] [PubMed]
12. Aziz, M.H.; Dreckschmidt, N.E.; Verma, A.K. Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer. Cancer Res. 2008, 68, 9024–9032. [CrossRef] [PubMed]
13. Thasni, K.A.; Rakesh, S.; Rojini, G.; Ratheeshkumar, T.; Srinivas, G.; Priya, S. Estrogen-dependent cell signaling and apoptosis in BRCA1-blocked BG1 ovarian cancer cells in response to plumbagin and other chemotherapeutic agents. Ann. Oncol. 2008, 19, 696–705. [CrossRef] [PubMed]
14. Gomathinayagam, R.; Sowmyalakshmi, S.; Mardhatillah, F.; Kumar, R.; Akbarsha, M.A.; Damodaran, C. Anticancer mechanism of plumbagin, a natural compound, on non-small cell lung cancer cells. Anticancer Res. 2008, 28, 785–792. [PubMed]
15. Wang, C.C.; Chiang, Y.M.; Sung, S.C.; Hsu, Y.L.; Chang, J.K.; Kuo, P.L. Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells. Cancer Lett. 2008, 259, 82–98. [CrossRef] [PubMed]
16. Shih, Y.W.; Lee, Y.C.; Wu, P.F.; Lee, Y.B.; Chiang, T.A. Plumbagin inhibits invasion and migration of liver cancer HepG2 cells by decreasing productions of matrix metalloproteinase-2 and urokinase-plasminogen activator. Hepatol. Res. 2009, 39, 998–1009. [CrossRef] [PubMed]
17. Anuf, A.R.; Ramachandran, R.; Krishnasamy, R.; Gandhi, P.S.; Periyasamy, S. Antiproliferative effects of Plumbago rosea and its purified constituent plumbagin on SK-MEL 28 melanoma cell lines. Pharmacogn. Res. 2014, 6, 312–319.
18. Gowda, R.; Sharma, A.; Robertson, G.P. Synergistic inhibitory effects of celecoxib and plumbagin on melanoma tumor growth. Cancer Lett. 2017, 385, 243–250. [CrossRef] [PubMed]
19. Li, J.; Shen, Q.; Peng, R.; Chen, R.; Jiang, P.; Li, Y.; Zhang, L.; Lu, J. Plumbagin enhances TRAIL-mediated apoptosis through up-regulation of death receptor in human melanoma A375 cells. J. Huazhong Univ. Sci. Technol. Med. Sci. 2010, 30, 458–463. [CrossRef] [PubMed]
20. Nair, S.; Nair, R.R.; Srinivas, P.; Srinivas, G.; Pillai, M.R. Radiosensitizing effects of plumbagin in cervical cancer cells is through modulation of the apoptotic pathway. Mol. Carcinog. 2008, 47, 22–33. [CrossRef] [PubMed]
21. Prasad, V.S.; Devi, P.U.; Rao, B.S.; Kamath, R. Radiosensitizing effect of plumbagin on mouse melanoma cells grown in vitro. Indian J. Exp. Biol. 1996, 34, 857–858. [PubMed]
22. Li, Y.C.; He, S.M.; He, Z.X.; Li, M.; Yang, Y.; Pang, J.X.; Zhang, X.; Chow, K.; Zhou, Q.; Duan, W.; et al. Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells. Cancer Lett. 2014, 344, 239–259. [CrossRef] [PubMed]
23. Checker, R.; Sharma, D.; Sandur, S.K.; Khanam, S.; Poduval, T.B. Anti-inflammatory effects of plumbagin are mediated by inhibition of NF-κB activation in lymphocytes. Int. Immunopharmacol. 2009, 9, 949–958. [CrossRef] [PubMed]
24. Kim, B.; Lee, S.H.; Choi, K.Y.; Kim, H.S. N-Nicotinoyl tyramine, a novel niacinamide derivative, inhibits melanogenesis by suppressing MITF gene expression. Eur. J. Pharmacol. 2015, 764, 1–8. [CrossRef] [PubMed]
25. Lee, H.Y.; Jang, E.J.; Bae, S.Y.; Jeon, J.E.; Park, H.J.; Shin, J.; Lee, S.K. Anti-melanogenic activity of Gauguin D, a highly oxygenated diterpenoid from the marine sponge Phorbas sp., via modulating tyrosinase expression and degradation. Mar. Drugs 2016, 14, 212. [CrossRef] [PubMed]
26. Winder, A.J.; Harris, H. New assays for the tyrosine hydroxylase and DOPA oxidase activities of tyrosinase. Eur. J. Biochem. 1991, 198, 317–326. [CrossRef] [PubMed]
For more info: david.deng@wecistanche.com WhatApp:86 13632399501






